A Study on the Use of Fluzoparib Combined With Chemotherapy for Neoadjuvant Treatment of HRD-positive, HR+/HER2- Breast Cancer
Clinical trial NCT07162051 · COMPLETED
Trial details
- NCT number
- NCT07162051
- Sponsor
- Xijing Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-03
- Primary completion
- 2026-02-15
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.